Your Web Site
Reuters Summit-UPDATE 2-Amgen tumor-starving drug gets spotlight? 1 hr ago
By Ransdell Pierson NEW YORK, Nov 18 (Reuters) - "It's new, we're ahead of the field and it has potential in a number of tumor types," Glenn Begley said at the Reuters Health Summit, calling the AMG 386 drug one of Amgen's most...
